In-vitro isolation and antifungal susceptibility of amphotericin B-resistant mutants of Aspergillus fumigatus

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 6, 1998, Pages 615-619

  Manavathu, Elias K ^a   Alangaden, George J ^a   Chandrasekar, Pranatharthi H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; GLUCOSE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NYSTATIN; PEPTONE; PYRROLE DERIVATIVE;

ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; CULTURE MEDIUM; DRUG RESISTANCE; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS MUTANT; MINIMUM INHIBITORY CONCENTRATION; MUTAGENESIS; NONHUMAN; ULTRAVIOLET IRRADIATION; YEAST;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; DRUG RESISTANCE, MICROBIAL; MICROBIAL SENSITIVITY TESTS; MICROBIOLOGICAL TECHNIQUES; ULTRAVIOLET RAYS;

EID: 0031842017     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.6.615     Document Type: Article

References (15)

1. Hutter, R. V. P., Lieberman, P. H. & Collins, H. S. (1964). Aspergillosis in a cancer hospital. Cancer 17, 747-56.
2. Bodey, G., Bueltmann, B., Duguid, W., Gibbs, D., Hanak, H., Hotchi, M. et al. (1992). Fungal infections in cancer patients: an international autopsy survey. European Journal of Clinical Microbiology and Infectious Diseases 11, 99-109.
3. Iwen, P. C., Reed, E. C., Armitage, J. O., Bierman, P. J., Kessinger, A., Vose, J. H. et al. (1993). Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem-cell transplants. Infection Control Hospital Epidemiology 14, 131-9.
4. Pannuti, C. S., Gingrich, R. D., Pfaller, M. A. & Wenzel, R. P. (1991). Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study. Journal of Clinical Oncology 9, 77-84.
5. Tolkoff-Rubin, N. E. & Rubin, R. H. (1992). Opportunistic fungal and bacterial infections in the renal transplant recipient. Journal of the American Society for Nephrology 2, Suppl. 12, S264-9.
6. Morrison, V. A., Haake, R. J. & Weisdorf, D. J. (1994). Noncandida fungal infections after bone marrow transplantation: risk factors and outcome. American Journal of Medicine 96, 497-503.
7. Patel, R. & Paya, C. V. (1997). Infections in solid-organ transplant recipients. Clinical Microbiology Reviews 10, 86-124.
8. Pursell, K. J., Telzak, E. E. & Armstrong, D. (1992). Aspergillus species colonization and invasive disease in patients with AIDS. Clinical Infectious Diseases 14, 141-8.
9. Khoo, S. H. & Denning, D. W. (1994). Invasive aspergillosis in patients with AIDS. Clinical Infectious Diseases 19, Suppl. 1, S41-8.
10. Denning, D. W. & Stevens, D. A. (1990). Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Review of Infectious Diseases 12, 1147-201.
11. Bodey, G. P. (1988). The emergence of fungi as major hospital pathogens. Journal of Hospital Infection 11, Suppl. A, 411-26.
12. Andriole, V. T. (1993). Infections with Aspergillus species. Clinical Infectious Diseases 17, Suppl. 2, S481-6.
13. Beck-Sague, C. M., Jarvis, W. R. & the National Nosocomial Inections Surveillance System. (1993). Secular trends in the epidemiology of nosocomial infections in the United States, 1980-1990. Journal of Infectious Diseases 167, 1247-51.
14. Manavathu, E. K., Alangaden, G. J. & Lerner, S. A. (1996). A comparative study of the broth micro-and macro-dilution techniques for the determination of the in vitro susceptibility of Aspergillus fumigatus. Canadian Journal of Microbiology 42, 960-4.
15. Espinel-Ingroff, A., Dawson, K., Pfaller, M., Anaissie, E., Breslin, B., Dixon, D. et al. (1995). Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrobial Agents and Chemotherapy 39, 314-19.